Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 43,218 | 31,860 | 29,387 | 32,581 | 30,446 |
| Operating Income | -43,218 | -31,860 | -29,387 | -32,581 | -30,446 |
| Other Income | 49 | 266 | 789 | 1,130 | 1,386 |
| Pre-tax Income | -43,169 | -31,594 | -28,598 | -31,451 | -29,060 |
| Income Tax | 667 | 5,875 | -2,179 | 346 | -2,002 |
| Net Income Continuous | -43,836 | -37,469 | -26,419 | -31,797 | -27,058 |
| Net Income | $-43,836 | $-37,469 | $-26,419 | $-31,797 | $-27,058 |
| EPS Basic Total Ops | -0.66 | -0.65 | -0.48 | -0.55 | -0.49 |
| EPS Basic Continuous Ops | -0.66 | -0.65 | -0.48 | -0.55 | -0.49 |
| EPS Diluted Total Ops | -0.66 | -0.65 | -0.48 | -0.55 | -0.49 |
| EPS Diluted Continuous Ops | -0.66 | -0.65 | -0.48 | -0.55 | -0.49 |
| EBITDA(a) | $-42,569 | $-31,265 | $-28,793 | $-32,015 | $-29,923 |